Kisspeptin Restores Pulsatile LH Secretion in Patients with Neurokinin B Signaling Deficiencies:Physiological, Pathophysiological and Therapeutic Implications [PDF]
Pulsatile gonadotropin-releasing hormone (GnRH) is crucial to normal reproductive function and abnormalities in pulse frequency give rise to reproductive dysfunction.
Young, Jacques +13 more
core +1 more source
Clinical development of the oral gonadotropin-releasing hormone antagonist elagolix
Elagolix is the first oral gonadotropin-releasing hormone antagonist that entered clinical development and received regulatory approval for the management of women with endometriosis and heavy menstrual bleeding associated with uterine fibroids in ...
Kristof Chwalisz, M.D., Ph.D.
doaj +1 more source
Gonadotropin releasing hormone analogs as part of controlled ovarian stimulation
I describe how we identified the need to block the luteinizing hormone (LH) surge when trying to control the processes of luteinization and ovulation within the clinic.
Richard Fleming, Ph.D.
doaj +1 more source
Gonadotrophin releasing hormone agonist with low dose human chorionic gonadotrophin co-triggers versus gonadotrophin releasing hormone agonist alone for reducing the risk of ovarian hyperstimulation in women with polycystic ovarian disease. [PDF]
Background: “Dual triggering” for final oocyte maturation using acombination of a gonadotropin-releasing hormone agonist (GnRHa) and human chorionic gonadotropin (hCG) can improve clinical outcomes in high responders during in vitro fertilization ...
Mohamed Gebreel +3 more
doaj +1 more source
Gonadotropin-releasing hormone (GnRH) is a fundamental driver of human reproduction. A pulsatile pattern of GnRH secretion is essential to achieve pituitary stimulation, gonadotropin secretion, and normal gonadal function.
Marco Filicori, M.D.
doaj +1 more source
Gonadotrophine Releasing Hormone Agonist As A Trigger of Ovulation in poly cystic ovary syndrome [PDF]
Gonadotropin-releasing hormone agonist (GnRH-a) has been used to suppress gonadotropins in several conditions including endometriosis, uterine fibroids, central gonadotropin- dependent precocious puberty, where gonadotropin suppression does not occur ...
Ayman Yousef +4 more
doaj +1 more source
Luteal-phase support in assisted reproductive technology: An ongoing challenge
It has been shown that in controlled ovarian hyper stimulation cycles, defective luteal phase is common. There are many protocols for improving pregnancy outcomes in women undergoing fresh and frozen in vitro fertilization cycles.
Saeideh Dashti, Maryam Eftekhar
doaj +1 more source
The role of Gai in the Gonadotropin-releasing hormone (GnRH) receptor inhibition of cell proliferation [PDF]
Includes abstract.Includes bibliographical references (leaves 72-78).The activation of Gonadotropin-releasing hormone receptor (GnRHR) by the GnRH ligand has been shown to mediate antiproliferative effects in extra-pituitary cells and in reproductive ...
Phillips, Pumza Samantha
core +1 more source
Investigation the polymorphism of gonadotropin releasing hormone receptor gene in Iraq sheep
In the present study, the investigation includes the estrus activity after synchronization of estrus by using 20 mg impregnated sponges with Medroxy Progesterone Acetate for 12 days with 400 IU I/M injection of pregnant mare serum gonadotropin 24 hrs ...
Hayder Abdul-Kareem Hasan AL-Mutar
doaj +1 more source
Fertility preservation in breast cancer with oral progestin: is it an option? A pilot study
Objective To compare the effectiveness of oral progestins and injectable gonadotropin-releasing hormone antagonist medication in cancer fertility preservation in patients with breast cancer.
Renato de Oliveira +5 more
doaj +2 more sources

